Quarterly ResultMay 6, 2026, 07:03 AM
Strata Critical Medical Q1 Revenue +87.4% to $67.4M; Net Income $2.4M
AI Summary
Strata Critical Medical reported strong first-quarter 2026 financial results, with total revenue increasing 87.4% year-over-year to $67.4 million. The company achieved net income from continuing operations of $2.4 million, a significant turnaround from a loss in the prior year. Adjusted EBITDA reached $6.4 million, and Strata completed a bolt-on acquisition of Ohio Valley Perfusion Associates while reiterating its full-year 2026 guidance.
Key Highlights
- Completed bolt-on acquisition of Ohio Valley Perfusion Associates for approximately $1 million.
- Total revenue increased 87.4% year-over-year to $67.4 million in Q1 2026.
- Net income from continuing operations was $2.4 million in Q1 2026, up from $(1.6) million in Q1 2025.
- Adjusted EBITDA was $6.4 million in Q1 2026, a 1440.9% increase year-over-year.
- Logistics revenue grew 32.4% year-over-year to $47.6 million.
- Clinical revenue grew 12.7% sequentially to $19.8 million in Q1 2026.
- Cash flow from operating activities was $3.9 million in Q1 2026.
- Reiterated full-year 2026 guidance: Revenue $260-275 million, Adjusted EBITDA $29-33 million.